• Mon news: Novartis Kisqali breast cancer trial. ESMO news: Bayer, Bristol Myers, Regeneron and more. Biosecure Act fallout. Boston Scientific/Silk Road merger. See more on our front page

Rob James and the e-mail eating IPADS

Anonymous

Guest
Novartis has deployed thousands of IPADs and these damn devices simply eat Novartis e-mails. Clearly Apple has again produced a faulty product... and poor Novartis CIO has become once again the victim of sloppy product development.
Sue Apple for such a discriminating device that only makes Novartis emails randomly vanish.

Never heart of others having such problems... Other people love that feature I guess.